$BNGO - Bionano

13-Nov-2024

The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, publishes a paper titled :

"Optical Genome Mapping (OGM) Identifies Multiple Structural Variants in a Case With Atypical Phelan-McDermid Syndrome"

The Phelan-McDermid Syndrome
1/8

$BNGO - Bionano

Watching our industry : 10x Genomics

Hamilton which has been providing workflow optimizations for pretty much all sequencing/genomic manufacturers (Illumina, PacBio, Bionano) finally "snares" 10x Genomics into a similar partnership.

www.marketscreener.com/quote/stock/...

$BNGO - Bionano

Watching our industry : PacBio

PacBio Q3 2024 results.

PacBio's Q3 results reflect the [severe] H2 2024 downturn in the industry (save for Illumina).

www.pacb.com/press_releas...

$BNGO - Bionano

Bionano files a preliminary proxy for a Reverse Split (and further dilution) for continued listing on Nasdaq and, more importantly, for survival.

Whether you vote FOR or AGAINST will result in a depressed SP, but the better outcome is to vote FOR.

www.sec.gov/Archives/edg...

The House Ethics Committee has voted not to release the Matt Gaetz report containing credible allegations of sexual misconduct including rape of a minor and sex trafficking.

5 Republicans and 5 Democrats each voted, and the parties deadlocked. Guess which side voted to cover up the crimes?

$BNGO - Bionano

Q3 2024 Earnings Call - (Part II - the details)

A) 5 sales per quarter is the current guidance going forward. Erik Holmlin was categorical when asked the question - the emphasis is on flowcell sales, management aims to be ultra prudent in its guidance at all times.
1/11